FDA, EMA Form Pharmacovigilance ‘Cluster’ to Speed Drug Safety Responses

The FDA and European Medicines Agency (EMA) have launched a new information-sharing initiative they hope will coordinate and speed international responses to drug safety problems.
Drug Industry Daily